apoA-1
Selected indexed studies
- High apoB/apoA-1 ratio is a strong risk predictor of major adverse cardio- and cerebrovascular events part 2: a review basis for updating guidelines. (Expert Rev Cardiovasc Ther, 2025) [PMID:40776757]
- The Relationship between Circulating APOA-1 and Atherosclerosis Initiation and Progression in Psoriasis. (J Invest Dermatol, 2023) [PMID:37088280]
- ApoA-1 versus HDL-C as markers of cardiovascular risk. (J Clin Lipidol, 2026) [PMID:41832071]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- High apoB/apoA-1 ratio is a strong risk predictor of major adverse cardio- and cerebrovascular events part 2: a review basis for updating guidelines. (2025) pubmed
- High apoB/apoA-1 ratio is a strong risk predictor of major adverse cardio- and cerebrovascular events part 1: a review basis for updating guidelines. (2025) pubmed
- The Relationship between Circulating APOA-1 and Atherosclerosis Initiation and Progression in Psoriasis. (2023) pubmed
- ApoA-1 versus HDL-C as markers of cardiovascular risk. (2026) pubmed
- ApoA-1 accelerates regeneration of small-for-size fatty liver graft after transplantation. (2018) pubmed
- Quantifying ABCA1/apoA-1 Signaling Pathways with AFM Imaging and Lipidomic Analysis. (2024) pubmed
- Serum apolipoproteins (apoA-1, apoB, and apoB/apoA-1 ratio) for early identification of dyslipidemia in children with CKD. (2024) pubmed
- Perilipin2/adipophilin and ApoA-1 team up to combat atherosclerosis. (2016) pubmed
- ApoA-1 improves glucose tolerance by increasing glucose uptake into heart and skeletal muscle independently of AMPKα(2). (2020) pubmed
- Relationship between ApoA-1, ApoB/ApoA-1 ratio, and preterm birth in patients with gestational diabetes mellitus in the third trimester. (2025) pubmed